Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gruenenthal
Pharma
AZ hands European Crestor rights to old customer Grünenthal
AZ has agreed to sign over Crestor rights in over 30 European countries—excluding the U.K. and Spain—for up to $350 million.
Angus Liu
Dec 1, 2020 10:50am
AstraZeneca gins up $815M in rights deal for Nexium, Vimovo
Oct 30, 2018 12:00pm
AZ offloads headache drug Zomig to Grünenthal to raise cash
Jun 7, 2017 9:56am
AZ jilts gout med Zurampic with $230M rights sale to Grunenthal
Jun 2, 2016 11:41am